Skip to main content

Table 3 The resistance rates of MDR-AB to 14 antimicrobial agents in the years 2013 to 2018 (%)

From: Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China

Antibiotics Total 2013 2014 2015 2016 2017 2018
Imipenem 100 100 100 100 100 100 100
Meropenem 100 100 100 100 100 100 100
Ceftazidime 100 100 100 100 100 100 100
Ceftriaxone 100 100 100 100 100 100 100
Gentamicin 98.2 100 100 96 100 93.8 100
Tobramycin 85.2 100 93.3 84 92 87.5 53.3
Ciprofloxacin 100 100 100 100 100 100 100
Levofloxacin 94.4 83.3 100 96 92 93.8 100
Ampicillin/sulbactam 99.1 100 100 100 100 93.8 100
Trimethoprim/sulfamethoxazole 76.7 100 13.3 56 52 93.8 100
Piperacillin/tazobactam 99.1 100 100 100 100 93.8 100
Cefperazone/sulbactam 77.8 83.3 66.7 80 80 75 80
Tigecycline 6.5 8.3 6.7 4 8 0 13.3
Polymyxin B 0 0 0 0 0 0 0